
Bristol-Myers Squibb Co (NYSE:BMY) Declines Because Of Unexpected Delay In Lung Cancer Drug Trial
Boston, MA 01/28/2014 (wallstreetpr) – Bristol-Myers Squibb Co (NYSE:BMY) reports a decline in share value in spite of last week’s more than expected quarterly results.












